Cashu | SRPT | News

HomeWatchlistNewsSignalsPicks

DJI

-0.61%

SPX

-0.08%

IXIC

+0.08%

FTSE

-0.56%

N225

0.00%

AXJO

0.00%

⌘K

HomeWatchlistNewsSignals

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Stocks

Health Care

srpt

Sarepta Therapeutics

NASDAQ: SRPT

-0.09 (-0.51%)

17.57

USD

At close at Mar 11, 20:37 UTC

Latest Sarepta Therapeutics News

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Feature Image for interests on Analyst Color, Expert Ideas, Healthcare, Stock from benzinga.com

Why Is uniQure Stock Skyrocketing Monday?

Feature Image for interests on Biotech, Fda, Health Care, Healthcare from benzinga.com

FDA reversals leave investors worrying about the fates of other experimental drugs

Feature Image for interests on Biotech And Pharmaceuticals, Breaking News: Politics, ETF, Financial Services from cnbc.com

'In a bit of chaos': FDA watchers warn about agency hemorrhaging staff and the risk to America's health

Feature Image for interests on Biotech And Pharmaceuticals, Breaking News: Politics, ETF, Healthcare from cnbc.com

Sarepta Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Feature Image for interests on Analyst Ratings, Bzi-Aar, Healthcare, Stock from benzinga.com

Sarepta CEO To Jump Ship After 'Tumultuous' Year

Feature Image for interests on Analyst Color, Benzai, Biotech, Expert Ideas from benzinga.com

Earnings Scheduled For February 25, 2026

Feature Image for interests on Basic Materials, Bzi-Ue, Communication Services, Consumer Cyclical from benzinga.com

Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Wednesday?

Feature Image for interests on Basic Materials, Commodities, Commodity Prices, Consumer Defensive from benzinga.com

Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements

Feature Image for interests on Biotech, Fda, Health Care, Healthcare from benzinga.com

Solid Biosciences: Better Positioned To Compete In DMD Gene Therapy, Says Bullish Analyst

Feature Image for interests on Analyst Color, Analyst Ratings, Gil Blum, Healthcare from benzinga.com

Join our newsletter to keep up to date with us!

Latest Cashu News

Regulatory Changes Could Boost Sarepta Therapeutics' Gene Therapy Innovations

Sarepta Therapeutics Faces Regulatory Scrutiny Amid FDA's Shifting Approval Standards for Rare Diseases

Challenges Faced by Sarepta Therapeutics Amid FDA's Regulatory Hurdles in Rare Disease Therapies